Analyst Price Targets — PACS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 2, 2026 2:07 pm | Ben Hendrix | RBC Capital | $52.00 | $37.45 | StreetInsider | PACS Group (PACS) PT Raised to $52 as RBC Capital Reiterates Top Pick |
| December 19, 2025 1:42 pm | Ben Hendrix | RBC Capital | $47.00 | $36.52 | StreetInsider | PACS Group (PACS) PT Raised to $47 at RBC Capital |
| December 18, 2025 12:12 pm | — | UBS | $42.00 | $34.68 | TheFly | Pacs Group resumed with a Buy at UBS |
| December 12, 2025 2:46 pm | — | Truist Financial | $40.00 | $33.89 | TheFly | Pacs Group price target raised to $40 from $32 at Truist |
| November 20, 2025 2:02 pm | — | RBC Capital | $33.00 | $25.31 | TheFly | Pacs Group price target raised to $33 from $32 at RBC Capital |
| August 15, 2024 8:17 am | David MacDonald | Truist Financial | $44.00 | $38.13 | StreetInsider | PACS Group (PACS) PT Raised to $44 at Truist Securities |
| August 13, 2024 7:30 am | Michael Wiederhorn | Oppenheimer | $40.00 | $32.35 | TheFly | Pacs Group price target raised to $40 from $32 at Oppenheimer |
| June 28, 2024 2:51 am | Tao Qiu | Macquarie | $35.00 | $30.19 | StreetInsider | Macquarie Starts PACS Group (PACS) at Outperform |
| May 15, 2024 7:35 am | Michael Wiederhorn | Oppenheimer | $32.00 | $26.91 | TheFly | Pacs Group price target raised to $32 from $31 at Oppenheimer |
| May 6, 2024 6:25 am | David MacDonald | Truist Financial | $32.00 | $24.81 | TheFly | Pacs Group initiated with a Buy at Truist |
Latest News for PACS
PHILADELPHIA, Pa., April 21, 2026 (GLOBE NEWSWIRE) -- Kaskela Law is investigating potential breach of fiduciary duty claims concerning PACS Group, Inc. (NYSE: PACS) (“PACS”) on behalf of the company's long-term shareholders.
PACS Group, Inc. (NYSE: PACS - Get Free Report) has been assigned a consensus rating of "Buy" from the six research firms that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the
SHEL, XYZ, UAA, PACS and LAUR have been added to the Zacks Rank #1 (Strong Buy) List on April 14, 2026.
The average of price targets set by Wall Street analysts indicates a potential upside of 31.2% in PACS Group, Inc. (PACS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Investors interested in stocks from the Medical Services sector have probably already heard of PACS Group, Inc. (PACS) and Medpace (MEDP). But which of these two companies is the best option for those looking for undervalued stocks?
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for PACS.
U.S. House Trading
No House trades found for PACS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.